EUROCELL (ASIA) LIMITED

EUROCELL (ASIA) LIMITED (Private company limited by shares) was incorporated on 1989-10-11 under the Companies Ordinance (Cap. 622) of Hong Kong. Pursuant to a special resolution delivered under Section 5 of Cap. 622, the corporation has entered dormant status, holding the legal status of [Dormant] (lawfully exempted from delivering annual returns while maintaining corporate personality) (Statutory records last verified: October 2026).

Official Hong Kong government registers assign two statutory identifiers to EUROCELL (ASIA) LIMITED: 1. Business Registration Number (BRN / UBI): [13121495] (statutory identifier for tax and commercial registration under Cap. 310); 2. Company Registration Number (CRN): [0264201] (statutory filing number under Cap. 622). Commercial counterparties should verify both numbers on contracts and invoices.

In Hong Kong corporate compliance and banking KYC due diligence, verifying the decision-makers of EUROCELL (ASIA) LIMITED requires cross-checking three statutory filings: 1. Latest Annual Return (Form NAR1) for issued share capital and shareholder equity percentages; 2. Form ND2A (Notice of Change of Company Secretary and Director) for interim board changes after the annual return date; and 3. Significant Controllers Register (SCR) penetration for natural persons or holding entities exercising ultimate control (UBO).

Yes. According to the official statutory records of the Hong Kong Companies Registry, EUROCELL (ASIA) LIMITED has officially recorded 2 legal name change(s): [GABARDINE LIMITED (effective 1989-10-11)], [EUROCELL (ASIA) LIMITED (effective 1990-03-16)]. Pursuant to Sections 107 and 109 of the Companies Ordinance (Cap. 622), each name change was passed by special resolution (Form NNC2) and took statutory effect upon issuance of a Certificate of Change of Name by the Registrar of Companies; under Section 109(4), changing the company name does not affect any rights, obligations, or legal proceedings of the company.

In Hong Kong corporate registration records, EUROCELL (ASIA) LIMITED has officially logged 10 statutory image filing(s) since incorporation (latest statutory filing indexed on 2023-12-27: Reference Document for Business Registration Number as UBI). Key authenticated filings include the latest Annual Return (Form NAR1 pursuant to Cap. 622 Section 662 - recording verified capital allocation, registered address, and director registers), original Incorporation documents (Form NNC1), and constitutional records, all authenticated with official ICRIS / e-Registry barcodes.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Register Screening: Multi-agency verification across Hong Kong statutory regulators confirms EUROCELL (ASIA) LIMITED does not hold special administrative or financial licences (such as SFC, HKMA, TCSP, or MSO), engaging in general commercial operations under the Companies Ordinance (Cap. 622); 2. Judicial Screening (Litigation & Winding-Up): public court records screening identified 1 public court docket(s) associated with this corporation; confirmed no compulsory winding-up petitions (HCCW) on file. Specific court levels (High Court HCA / District Court DCCJ), case numbers, party capacities, and judgments are accessible via official Due Diligence Reports.

The statutory registered office of EUROCELL (ASIA) LIMITED is registered at: [ROOM 1101, 11/F, 88 HING FAT STREET, CAUSEWAY BAY, HONG KONG]. Official registry dossiers also record 1 statutory registered office address change filing(s) (Form NR1). In accordance with Cap. 622 Section 658 and Cap. 622B Section 3, this Hong Kong address serves as the statutory venue for inspection of statutory registers, service of government and judicial process, and mandatory display of the corporation's full legal name.

Before entering into cross-border trade, credit settlement, or joint venture agreements with EUROCELL (ASIA) LIMITED (CRN: 0264201 / 8-digit BRN: 13121495), standard institutional due diligence under Hong Kong law comprises four core verifications: 1. Standing & Identifier Match: Cross-checking active status under Cap. 622 and its 8-digit BRN under Cap. 310; 2. Equity & Signatory Penetration: Inspecting the latest Annual Return (Form NAR1) and Form ND2A to verify paid-up share capital, shareholders, and authorized signatory directors; 3. Register of Charges Screening: Checking Form NM1 filings under Part 8 (Section 334) of Cap. 622 for pledged corporate assets or bank floating charges; and 4. Judicial Screening: Verifying the absence of High Court winding-up petitions (HCCW) or civil litigation writs.